Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cystic Fibrosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cystic Fibrosis
    TopAbstracts in Cystic Fibrosis 11/17/2008 - (DGNews)
    New Test May Accurately Measure Patients' Response to Cystic Fibrosis Therapy - (DGNews)
    TopAbstracts in Cystic Fibrosis 10/20/2008 - (DGNews)
    Pirfenidone Approved in Japan for Treatment of Idiopathic Pulmonary Fibrosis - (DGNews)
    Children With Cystic Fibrosis Not Well Covered by Guidelines for Vitamin D Needs - (DGNews)

    News archive

     Recent webcasts/CME - Cystic Fibrosis
      Diagnosis of Cystic Fibrosis
      Aggressive Treatment Strategies in the Fight Against Cystic Fibrosis

      Webcasts/CME archive

       Recent cases - Cystic Fibrosis
        An Atypical Presentation of Cystic Fibrosis: A Case Report
        Cystic Fibrosis Presenting as Recurrent Pancreatitis in a Young Child with a Normal Sweat Test and Pancreas Divisum: A Case Report
        Extracorporeal Membrane Oxygenator as a Bridge to Successful Surgical Repair of Bronchopleural Fistula Following Bilateral Sequential Lung Transplantation; A Case Report and Review of Literature
        Cystic Fibrosis and Renal Disease: A Case Report
        Inhaled Tobramycin Solution-Associated Recurrent Eosinophilia and Severe Persistent Bronchospasm in a Patient with Cystic Fibrosis: A Case Report

        Cases archive
          




        my personal edition > cystic fibrosis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Alcaligenes Infection Does Not Worsen Cystic Fibrosis

        A DGReview of :"Alcaligenes infection in cystic fibrosis"
        Pediatric Pulmonology

        08/09/2002
        By Mark Pownall


        Respiratory infection with Alcaligenes species appears to have little effect on the clinical status of patients with cystic fibrosis, a small study suggests.

        Cystic fibrosis (CF) patients are rarely infected with chronic Alcaligenes species infection, researchers report, and the one in 50 that is infected has similar rates of decline in clinical and pulmonary function as do CF patients without the infection.

        The findings come from a study of a clinic population of 557, who were also found to have no excess deterioration in clinical and pulmonary measures in the two years before infection compared to the two years after.

        The researchers, from the cystic fibrosis unit at the University of Leeds, England, found that only 13 patients (2.3 percent) were chronically infected with Alcaligenes, as determined by positive sputum cultures three or more times over a period of six months.

        Patients were compared to other CF patients and were matched for age, gender, respiratory function test results, Pseudomonas aeruginosa infection.

        Researchers compared respiratory function results, anthropometric measurements, Shwachman-Kulczycki scores, Northern chest X-ray scores, use of intravenous and nebulized antibiotics and corticosteroid treatment, which were all measured for the two years before and two years after Alcaligenes was diagnosed.

        There were no significant changes for forced expiratory volume in one second, forced vital capacity, and forced expiratory flow at 25%-75% of maximal lung volume, or in the Shwachman-Kulczycki scores or Northern chest X-ray scores. Similarly there was no difference in height, weight, or body mass index z-scores, between the Alcaligenes-infected patients and the controls. There was also no difference between the two groups of patients in their use of intravenous or nebulized antibiotics nor their use or oral or inhaled steroids.
        Pediatric Pulmonology 2002; 34: 101-104. "Alcaligenes infection in cystic fibrosis"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send